|
1
|
Schlenk RF: Post-remission therapy for
acute myeloid leukemia. Haematologica. 99:1663–1670. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mrózek K, Marcucci G, Nicolet D, Maharry
KS, Becker H, Whitman SP, Metzeler KH, Schwind S, Wu YZ,
Kohlschmidt J, et al: Prognostic significance of the European
LeukemiaNet standardized system for reporting cytogenetic and
molecular alterations in adults with acute myeloid leukemia. J Clin
Oncol. 30:4515–4523. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Morceau F, Chateauvieux S, Orsini M,
Trécul A, Dicato M and Diederich M: Natural compounds and
pharmaceuticals reprogram leukemia cell differentiation pathways.
Biotechnol Adv. 33:785–797. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sui M, Zhang Z and Zhou J: Inhibition
factors of arsenic trioxide therapeutic effects in patients with
acute promyelocytic leukemia. Chin Med J (Engl). 127:3503–3506.
2014.
|
|
5
|
Gallagher RE: Retinoic acid resistance in
acute promyelocytic leukemia. Leukemia. 16:1940–1958. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sanz MA and Montesinos P: How we prevent
and treat differentiation syndrome in patients with acute
promyelocytic leukemia. Blood. 123:2777–2782. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kweon SH, Song JH, Kim HJ, Kim TS and Choi
BG: Induction of human leukemia cell differentiation via PKC/MAPK
pathways by arsantin, a sesquiterpene lactone from Artemisia
santolina. Arch Pharm Res. 38:2020–2028. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yi L and Su Q: Molecular mechanisms for
the anticancer effects of diallyl disulfide. Food Chem Toxicol.
57:362–370. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sundaram SG and Milner JA: Diallyl
disulfide suppresses the growth of human colon tumor cell
xenografts in athymic nude mice. J Nutr. 126:1355–1361.
1996.PubMed/NCBI
|
|
10
|
Yi L, Ji XX, Lin M, Tan H, Tang Y, Wen L,
Ma YH and Su Q: Diallyl disulfide induces apoptosis in human
leukemia HL-60 cells through activation of JNK mediated by reactive
oxygen. Pharmazie. 65:693–698. 2010.PubMed/NCBI
|
|
11
|
Yi L, Ji XX, Tan H, Feng MY, Tang Y, Wen L
and Su Q: Involvement of Mcl1 in diallyl disulfide-induced G2/M
cell cycle arrest in HL-60 cells. Oncol Rep. 27:1911–1917.
2012.PubMed/NCBI
|
|
12
|
Gharahdaghi F, Weinberg CR, Meagher DA,
Imai BS and Mische SM: Mass spectrometric identification of
proteins from silver-stained polyacrylamide gel: A method for the
removal of silver ions to enhance sensitivity. Electrophoresis.
20:601–605. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ling H, Zhang LY, Su Q, Song Y, Luo ZY,
Zhou XT, Zeng X, He J, Tan H and Yuan JP: Erk is involved in the
differentiation induced by diallyl disulfide in the human gastric
cancer cell line MGC803. Cell Mol Biol Lett. 11:408–423. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lai KC, Hsu SC, Kuo CL, Yang JS, Ma CY, Lu
HF, Tang NY, Hsia TC, Ho HC and Chung JG: Diallyl sulfide, diallyl
disulfide, and diallyl trisulfide inhibit migration and invasion in
human colon cancer colo 205 cells through the inhibition of matrix
metalloproteinase-2, -7, and -9 expressions. Environ Toxicol.
28:479–488. 2013. View Article : Google Scholar
|
|
15
|
Nagakubo D, Taira T, Kitaura H, Ikeda M,
Tamai K, Iguchi-Ariga SM and Ariga H: DJ-1, a novel oncogene which
transforms mouse NIH3T3 cells in cooperation with ras. Biochem
Biophys Res Commun. 231:509–513. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou X, Xu N, Li R, Xiao Y, Gao G, Lu Q,
Ding L, Li L, Li Y, Du Q, et al: A comparative proteomic study of
Homoharringtonine-induced apoptosis in leukemia K562 cells. Leuk
Lymphoma. 56:2162–2169. 2015. View Article : Google Scholar
|
|
17
|
Liu H, Wang M, Li M, Wang D, Rao Q, Wang
Y, Xu Z and Wang J: Expression and role of DJ-1 in leukemia.
Biochem Biophys Res Commun. 375:477–483. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bai J, Guo C, Sun W, Li M, Meng X, Yu Y,
Jin Y, Tong D, Geng J, Huang Q, et al: DJ-1 may contribute to
metastasis of non-small cell lung cancer. Mol Biol Rep.
39:2697–2703. 2012. View Article : Google Scholar
|
|
19
|
Lee H, Choi SK and Ro JY: Overexpression
of DJ-1 and HSP90α, and loss of PTEN associated with invasive
urothelial carcinoma of urinary bladder: Possible prognostic
markers. Oncol Lett. 3:507–512. 2012.PubMed/NCBI
|
|
20
|
Kim YC, Kitaura H, Taira T, Iguchi-Ariga
SM and Ariga H: Oxidation of DJ-1-dependent cell transformation
through direct binding of DJ-1 to PTEN. Int J Oncol. 35:1331–1341.
2009.PubMed/NCBI
|
|
21
|
Vasseur S, Afzal S, Tomasini R,
Guillaumond F, Tardivel-Lacombe J, Mak TW and Iovanna JL:
Consequences of DJ-1 upregulation following p53 loss and cell
transformation. Oncogene. 31:664–670. 2012.
|
|
22
|
Zhou J, Wang Y, Fei J and Zhang W:
expression of cofilin 1 is positively correlated with the
differentiation of human epithelial ovarian cancer. Oncol Lett.
4:1187–1190. 2012.PubMed/NCBI
|
|
23
|
Harris W, Sachana M, Flaskos J and
Hargreaves AJ: Proteomic analysis of differentiating neuroblastoma
cells treated with sublethal neurite inhibitory concentrations of
diazinon: Identification of novel biomarkers of effect. Toxicol
Appl Pharmacol. 240:159–165. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Heasman SJ and Ridley AJ: Mammalian Rho
GTPases: New insights into their functions from in vivo studies.
Nat Rev Mol Cell Biol. 9:690–701. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Koh SA, Kim MK, Lee KH, Kim SW and Kim JR:
RhoGDI2 is associated with HGF-mediated tumor invasion through VEGF
in stomach cancer. Clin exp Metastasis. 31:805–815. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fang Y, Yi J, Lizhi L and Qiucheng C: Rho
GDP dissociation inhibitor beta promotes cell proliferation and
invasion by modulating the AKT pathway in hepatocellular carcinoma.
DNA Cell Biol. 33:781–786. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
López-Pedrera C, Villalba JM, Siendones E,
Barbarroja N, Gómez-Díaz C, Rodríguez-Ariza A, Buendía P, Torres A
and Velasco F: Proteomic analysis of acute myeloid leukemia:
Identification of potential early biomarkers and therapeutic
targets. Proteomics. 6(Suppl 1): S293–S299. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Griner EM and Theodorescu D: The faces and
friends of RhoGDI2. Cancer Metastasis Rev. 31:519–528. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Griner EM, Dancik GM, Costello JC, Owens
C, Guin S, Edwards MG, Brautigan DL, Theodorescu D and Rho C: RhoC
is an unexpected target of RhoGDI2 in prevention of lung
colonization of bladder cancer. Mol Cancer Res. 13:483–492. 2015.
View Article : Google Scholar :
|
|
30
|
Zamanian M, Veerakumarasivam A, Abdullah S
and Rosli R: Calreticulin and cancer. Pathol Oncol Res. 19:149–154.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Weng WC, Lin KH, Wu PY, Lu YC, Weng YC,
Wang BJ, Liao YF, Hsu WM, Lee WT and Lee H: Calreticulin regulates
VEGF-A in neuroblastoma cells. Mol Neurobiol. 52:758–770. 2015.
View Article : Google Scholar
|
|
32
|
Lu YC, Weng WC and Lee H: Functional roles
of calreticulin in cancer biology. Biomed Res Int. 2015:5265242015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Caputo E, Maiorana L, Vasta V, Pezzino FM,
Sunkara S, Wynne K, Elia G, Marincola FM, McCubrey JA, Libra M, et
al: Characterization of human melanoma cell lines and melanocytes
by proteome analysis. Cell Cycle. 10:2924–2936. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Qin H, Liu T, Yang JL, Huang X, Liu B,
Song X, Zhao X and Wei YQ: Screening proteins related to retinoic
acid resistance by proteomic analysis. Zhonghua Yi Xue Za Zhi.
87:520–525. 2007.In Chinese. PubMed/NCBI
|
|
35
|
Wang SC: PCNA: A silent housekeeper or a
potential therapeutic target? Trends Pharmacol Sci. 35:178–186.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhu Q, Chang Y, Yang J and Wei Q:
Post-translational modifications of proliferating cell nuclear
antigen: A key signal integrator for DNA damage response (Review).
Oncol Lett. 7:1363–1369. 2014.PubMed/NCBI
|
|
37
|
Calaf GM, Echiburú-Chau C, Wen G, Balajee
AS and Roy D: Effect of curcumin on irradiated and
estrogen-transformed human breast cell lines. Int J Oncol.
40:436–442. 2012.
|
